Literature DB >> 28927754

Motility disorders in infants.

I J N Koppen1, M A Benninga2, M M J Singendonk3.   

Abstract

Gastrointestinal motility disorders are common in the pediatric population and may affect the entire gastrointestinal tract and can vary from mild to severe conditions. They may clinically manifest as gastro-esophageal reflux symptoms, feeding difficulties and failure to thrive, constipation and diarrhea amongst others. This review first highlights the embryologic development of the gastrointestinal tract, after which the prenatal and neonatal development of gastrointestinal motility is discussed. Normal motility patterns as seen in (preterm) infants are described as a background for the discussion of the most common congenital and acquired motility disorders in infancy. This review specifically focuses on the role of preterm birth on the development of these disorders.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Constipation; Gastrointestinal motility; Infants; Reflux

Mesh:

Year:  2017        PMID: 28927754     DOI: 10.1016/j.earlhumdev.2017.09.005

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  3 in total

1.  Electroacupuncture to Increase Neuronal Stem Cell Growth.

Authors:  Genia Dubrovsky; Don Ha; Anne-Laure Thomas; Minji Zhu; John Hubacher; Tatsuo Itoh; James C Y Dunn
Journal:  Med Acupunct       Date:  2020-02-03

2.  MIRAGE syndrome with recurrent pneumonia probably associated with gastroesophageal reflux and achalasia: A case report.

Authors:  Kanako Yoshizaki; Rumi Hachiya; Yutaro Tomobe; Uiko Kaku; Kazuhisa Akiba; Hirohito Shima; Satoshi Narumi; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2019-10-19

Review 3.  Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.

Authors:  Anna Rybak; Aruna Sethuraman; Kornilia Nikaki; Jutta Koeglmeier; Keith Lindley; Osvaldo Borrelli
Journal:  Nutrients       Date:  2020-11-18       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.